BridgeMD
Compares treatment options for Hemodynamics Instability
Official title Evaluating Perioperative Outcomes: Dexmedetomidine vs Lignocaine in Laparoscopic Chlolecystectomy
ClinicalTrials.gov ID: NCT06740903
What this study is testing
What is inj. dexmedetomidine infusion @ 0.2-0.4 μg/kg/h?
inj. dexmedetomidine infusion @ 0.2-0.4 μg/kg/h is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for hemodynamics instability.
Also referred to as Precedex.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Nowadays laparoscopic surgery is the first choice for many surgeries. Such surgeries have revolutionized the surgical practice and has markedly reduced the incidence of intraoperative and postoperative complications.
- Phase 3: a large, late-stage study
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 70. Healthy volunteers may be eligible.
You may be able to join if
- Patients of age 20-70 years
- Both gender
- Laparoscopic cholecystectomy under general Anaesthesia
- ASA I-II.
You likely can't join if
- Emergency surgery
- Patients with history of allergic reaction to trial drugs
- Patients with cardiovascular disease, sickle cell disease, psychiatric disorder, peripheral vascular disease, and neurological diseases (on medical...
- Anemia
- Patient on TCA or Beta blocker drugs.
- Uncontrolled hypertension (P≥160/100 mmHg)
See the full eligibility criteria
- Patients of age 20-70 years
- Both gender
- Laparoscopic cholecystectomy under general Anaesthesia
- ASA I-II.
- Emergency surgery
- Patients with history of allergic reaction to trial drugs
- Patients with cardiovascular disease, sickle cell disease, psychiatric disorder, peripheral vascular disease, and neurological diseases (on medical record)
- Anemia
- Patient on TCA or Beta blocker drugs.
- Uncontrolled hypertension (P≥160/100 mmHg)
- Uncontrolled diabetes mellitus
- Obesity BMI \> 35
The study team makes the final eligibility decision.
Where it's taking place
- Sahiwal, Punjab Province, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 70 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Sahiwal, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.